Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Garzotto

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Urology|February 14, 2006
Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsyStephen E F Spurgeon, Yi-Ching Hsieh, Adrianna Rivadinera, et al.
Cancer Research|September 3, 2010
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancerMeng-Lei Zhu, Craig M Horbinski, Mark Garzotto, et al.
The Journal of Urology|March 30, 2019
Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph NodesNicholas Chakiryan, Ann Martinez, Lina Gao, et al.
Oncology|November 24, 2004
Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigenIrene Panagiotou, Tomasz M Beer, Yi-Ching Hsieh, et al.
American Journal of Epidemiology|July 15, 2005
Statins and prostate cancer risk: a case-control studyJackilen Shannon, Selome Tewoderos, Mark Garzotto, et al.
American Journal of Clinical Pathology|March 17, 2010
Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancerCatherine O'Brien, Lawrence D True, Celestia S Higano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Effect of calcitriol on prostate-specific antigen in vitro and in humansTomasz M Beer, Mark Garzotto, Byung Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.
The Journal of Urology|March 27, 2007
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes studyJulie N Graff, Motomi Mori, Hong Li, et al.
Nutrition and Cancer|October 20, 2009
Folate intake and prostate cancer risk: a case-control studyJackilen Shannon, Elena Phoutrides, Amy Palma, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Urology|February 14, 2006
Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsyStephen E F Spurgeon, Yi-Ching Hsieh, Adrianna Rivadinera, et al.
Cancer Research|September 3, 2010
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancerMeng-Lei Zhu, Craig M Horbinski, Mark Garzotto, et al.
The Journal of Urology|March 30, 2019
Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph NodesNicholas Chakiryan, Ann Martinez, Lina Gao, et al.
Oncology|November 24, 2004
Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigenIrene Panagiotou, Tomasz M Beer, Yi-Ching Hsieh, et al.
American Journal of Epidemiology|July 15, 2005
Statins and prostate cancer risk: a case-control studyJackilen Shannon, Selome Tewoderos, Mark Garzotto, et al.
American Journal of Clinical Pathology|March 17, 2010
Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancerCatherine O'Brien, Lawrence D True, Celestia S Higano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Effect of calcitriol on prostate-specific antigen in vitro and in humansTomasz M Beer, Mark Garzotto, Byung Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.
The Journal of Urology|March 27, 2007
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes studyJulie N Graff, Motomi Mori, Hong Li, et al.
Nutrition and Cancer|October 20, 2009
Folate intake and prostate cancer risk: a case-control studyJackilen Shannon, Elena Phoutrides, Amy Palma, et al.
Pageof 8